Company Profile

Lifetime Omics Inc
Profile last edited on: 8/4/2022      CAGE: 89TD6      UEI: CDENBM2B9K63

Business Identifier: Personalized health diagnosis
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

758 NE 90th Street Unit 507
Miami Shores, FL 33138
Location: Single
Congr. District: 24
County: Miami-Dade

Public Profile

Offering personalized health diagnosis to the medical field and to organizations and/or communities of people having a shared health concern, Lifetime Omics makes application of the latest biotechnology and scientific methods: predicting Infectious disease progression and outcomes with Metagenomics and AI. In effect, the firm measures people’s health and provides knowledge with actionable insights. This is accomplished by using Semantic-Web-driven cloud computing analytics, access to a network of omics laboratories, and to scientists at research institutions - th latter of which join an omics project to innovate a medical procedure and to create better clinical practices, or to optimize the health of a community to help people thrive. Scientists have developed innovative omics technologies - eg genome and microbiome sequencing - able measure everything in the human body (all molecules, all microbes: bacteria, viruses, protozoa and fungi), aeffectively also demonstarting that everything is interconnected: health, diet, genes, omicrobes, the metabolites in our blood, brain functions, even moods. There is a gap in current medicine as it lags behind in providing continuous insights derived from biotechnology and omics-enabled solutions that are not available at the doctor’s office. Lifeime Omics is structured such as to provide omics-enabled health profiling, and correlation analysis between different types of omics data. Example: bacteria in the gut, as in microbiomics, and MRI brain image features, as in radiomics. The firm's offered solutions leverage omics science, the power of the cloud, knowledge graph technologies, AI, and access to data scientists to advance personalized medicine for everyone.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $278,889
Project Title: In Vivo Cluster AI Prediction (CLAIRE) of COVID-19 Disease Progression

Key People / Management

  Patricia Buendia -- CEO

  Krystal Fernandez -- Clinical Research Manager

Company News

There are no news available.